- Home
- GORV vs GDTC Comparison
GORV vs GDTC Comparison
Compare GORV & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GORV
- GDTC
- Stock Information
- Founded
- GORV 1976
- GDTC 2018
- Country
- GORV United States
- GDTC Singapore
- Employees
- GORV N/A
- GDTC N/A
- Industry
- GORV Retail-Auto Dealers and Gas Stations
- GDTC Biotechnology: Pharmaceutical Preparations
- Sector
- GORV Consumer Discretionary
- GDTC Health Care
- Exchange
- GORV Nasdaq
- GDTC Nasdaq
- Market Cap
- GORV 25.3M
- GDTC 21.5M
- IPO Year
- GORV 2015
- GDTC 2023
- Fundamental
- Price
- GORV $5.42
- GDTC $1.89
- Analyst Decision
- GORV Hold
- GDTC Buy
- Analyst Count
- GORV 2
- GDTC 1
- Target Price
- GORV $60.00
- GDTC $5.00
- AVG Volume (30 Days)
- GORV 37.9K
- GDTC 18.1K
- Earning Date
- GORV 08-15-2025
- GDTC 01-01-0001
- Dividend Yield
- GORV N/A
- GDTC N/A
- EPS Growth
- GORV N/A
- GDTC N/A
- EPS
- GORV N/A
- GDTC N/A
- Revenue
- GORV $767,257,000.00
- GDTC $368,838.00
- Revenue This Year
- GORV $15.65
- GDTC $5.37
- Revenue Next Year
- GORV $20.54
- GDTC N/A
- P/E Ratio
- GORV N/A
- GDTC N/A
- Revenue Growth
- GORV N/A
- GDTC N/A
- 52 Week Low
- GORV $3.95
- GDTC $1.20
- 52 Week High
- GORV $98.40
- GDTC $4.05
- Technical
- Relative Strength Index (RSI)
- GORV 33.87
- GDTC 37.08
- Support Level
- GORV $6.01
- GDTC $1.85
- Resistance Level
- GORV $6.74
- GDTC $1.95
- Average True Range (ATR)
- GORV 0.74
- GDTC 0.10
- MACD
- GORV -0.11
- GDTC -0.02
- Stochastic Oscillator
- GORV 10.20
- GDTC 28.00
About GORV Lazydays Holdings Inc.
Lazydays Holdings Inc operates recreational vehicle dealerships. It provides products and services for RV owners and outdoor enthusiasts. The company generates revenue by providing a full spectrum of RV products: New and pre-owned RV sales, RV parts and services, financing and insurance products, third-party protection plans, after-market parts and accessories, and RV camping facilities.
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.